SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-11-070527
Filing Date
2011-12-19
Accepted
2011-12-19 16:51:54
Documents
4
Period of Report
2011-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v243388_8-k.htm 8-K 28033
2 EXHIBIT 10.1 v243388_ex10-1.htm EX-10.1 22375
3 EXHIBIT 10.2 v243388_ex10-2.htm EX-10.2 24591
4 GRAPHIC logo.jpg GRAPHIC 5818
  Complete submission text file 0001144204-11-070527.txt   84500
Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019
Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950
MANHATTAN PHARMACEUTICALS INC (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 111269699
SIC: 2834 Pharmaceutical Preparations